Four‐day plaque regrowth evaluation of a peptide chewing gum in a double‐blind randomized clinical trial

OBJECTIVE: Antimicrobial peptide, KSL‐W, formulated as an antiplaque chewing gum (APCG), was tested to evaluate the dental plaque inhibition activity and safety in an IRB approved and FDA regulated 4‐day plaque regrowth clinical study. METHODS: This Phase 2 two‐armed placebo‐controlled, double blind...

Descripción completa

Detalles Bibliográficos
Autores principales: Kirkwood, Brian, Miller, Michael, Milleman, Jeffery, Milleman, Kimberly, Leung, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301399/
https://www.ncbi.nlm.nih.gov/pubmed/32558314
http://dx.doi.org/10.1002/cre2.275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301399/
https://www.ncbi.nlm.nih.gov/pubmed/32558314
http://dx.doi.org/10.1002/cre2.275

Ejemplares similares